Correlation Engine 2.0
Clear Search sequence regions


  • anthrax (8)
  • anthrax vaccines (4)
  • antibodies (4)
  • history (2)
  • humans (1)
  • vaccines (2)
  • Sizes of these terms reflect their relevance to your search.

    Vaccines and therapeutic antibodies are the most crucial components of anthrax prophylaxis (pre- and post-exposure) and treatment. The improvement in the availability and safety profile of vaccines and the therapeutic antibodies has helped immensely in reducing the worldwide burden of anthrax. Current recommendations for anthrax prophylaxis and control, vaccines and therapeutic antibodies, the recent endeavors, particularly, made after 2010 toward making them safer and more efficacious along with our opinion on its future course. Primarily, PubMed and Europe PMC were searched to cover the recent developments in the above-indicated areas. Some key existing lacunae in our understanding of the working of biologicals-based anthrax-control measures, i.e., vaccines and therapeutic antibodies, should be addressed to improve their overall stability, safety profile, and efficacy. The identification of novel inhibitors targeting different key-molecules and vital-steps contributing to the overall anthrax pathophysiology could make a difference in anthrax control.

    Citation

    Manish Manish, Shashikala Verma, Divya Kandari, Parul Kulshreshtha, Samer Singh, Rakesh Bhatnagar. Anthrax prevention through vaccine and post-exposure therapy. Expert opinion on biological therapy. 2020 Dec;20(12):1405-1425

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32729741

    View Full Text